rs11536891
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_138554.5(TLR4):c.*2411T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 152,116 control chromosomes in the GnomAD database, including 2,123 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.16 ( 2122 hom., cov: 32)
Exomes 𝑓: 0.21 ( 1 hom. )
Consequence
TLR4
NM_138554.5 3_prime_UTR
NM_138554.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0750
Publications
46 publications found
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.212 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TLR4 | NM_138554.5 | c.*2411T>C | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000355622.8 | NP_612564.1 | ||
| TLR4 | NM_003266.4 | c.*2411T>C | 3_prime_UTR_variant | Exon 4 of 4 | NP_003257.1 | |||
| TLR4 | NM_138557.3 | c.*2411T>C | 3_prime_UTR_variant | Exon 2 of 2 | NP_612567.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TLR4 | ENST00000355622.8 | c.*2411T>C | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_138554.5 | ENSP00000363089.5 | |||
| ENSG00000285082 | ENST00000697666.1 | c.140+8330T>C | intron_variant | Intron 3 of 4 | ENSP00000513391.1 |
Frequencies
GnomAD3 genomes AF: 0.162 AC: 24591AN: 151986Hom.: 2112 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24591
AN:
151986
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.214 AC: 3AN: 14Hom.: 1 Cov.: 0 AF XY: 0.300 AC XY: 3AN XY: 10 show subpopulations
GnomAD4 exome
AF:
AC:
3
AN:
14
Hom.:
Cov.:
0
AF XY:
AC XY:
3
AN XY:
10
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
0
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
2
AN:
10
Other (OTH)
AF:
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.162 AC: 24633AN: 152102Hom.: 2122 Cov.: 32 AF XY: 0.157 AC XY: 11700AN XY: 74364 show subpopulations
GnomAD4 genome
AF:
AC:
24633
AN:
152102
Hom.:
Cov.:
32
AF XY:
AC XY:
11700
AN XY:
74364
show subpopulations
African (AFR)
AF:
AC:
8949
AN:
41486
American (AMR)
AF:
AC:
2013
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
701
AN:
3470
East Asian (EAS)
AF:
AC:
561
AN:
5164
South Asian (SAS)
AF:
AC:
573
AN:
4820
European-Finnish (FIN)
AF:
AC:
962
AN:
10602
Middle Eastern (MID)
AF:
AC:
42
AN:
292
European-Non Finnish (NFE)
AF:
AC:
10414
AN:
67968
Other (OTH)
AF:
AC:
328
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1048
2096
3143
4191
5239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
262
524
786
1048
1310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
441
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.